Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Multimodal gold nanoparticles as potential radiopharmaceuticals in targeted radionuclide therapy

2018/31/D/ST4/01488

Keywords:

radiopharmaceuticals cancer cells gold nanoparticles chemotherapeutic doxorubicin neuroendocrine tumours

Descriptors:

  • ST4_16: Ionic liquids
  • ST4_2: Spectroscopic and spectrometric techniques
  • ST4_18: Radiation and nuclear chemistry

Panel:

ST4 - Chemistry: physical chemistry/chemical physics, theoretical chemistry, analytical chemistry, inorganic chemistry, organic chemistry, method development

Host institution :

Instytut Chemii i Techniki Jądrowej

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Agnieszka Majkowska-Pilip 

Number of co-investigators in the project: 4

Call: SONATA 14 - announced on 2018-09-14

Amount awarded: 776 400 PLN

Project start date (Y-m-d): 2019-07-01

Project end date (Y-m-d): 2023-06-30

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. komputer z oprogramowaniem (10 000 PLN)
  2. mikroskop fluorescencyjny wraz z kamerą (100 000 PLN)

Information in the final report

  • Publication in academic press/journals (4)
  1. Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers
    Authors:
    K. Żelechowska-Matysiak, K. Wawrowicz, M. Wierzbicki, T. Budlewski, A. Bilewicz, A. Majkowska-Pilip
    Academic press:
    Molecules (rok: 2023, tom: 28(6), strony: 2451), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules28062451 - link to the publication
  2. Improvement of the effectiveness of HER2+ cancer therapy by use of doxorubicin and trastuzumab modified radioactive gold nanoparticles
    Authors:
    Kinga Żelechowska-Matysiak, Evangelia-Alexandra Salvanou, Penelope Bouziotis, Tadeusz Budlewski, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
    Academic press:
    Molecular Pharmceutics (rok: 2023, tom: 20, strony: 4676-4686), Wydawca: ACS
    Status:
    Published
    DOI:
    10.1021/acs.molpharmaceut.3c00414 - link to the publication
  3. Lipidic Cubic-Phase Nanoparticles (Cubosomes) Loaded with Doxorubicin and Labeled with 177Lu as a Potential Tool for Combined Chemo and Internal Radiotherapy for Cancers
    Authors:
    Adrianna Cytryniak, Ewa Nazaruk, Renata Bilewicz, Emilia Górzyńska, Kinga Żelechowska-Matysiak, Rafał Walczak, Adam Mames, Aleksander Bilewicz, Agnieszka Majkowska-Pilip*
    Academic press:
    Nanomaterials (rok: 2020, tom: 10, strony: 2286), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/nano10112272 - link to the publication
  4. Nanoparticles in Targeted Alpha Therapy
    Authors:
    Agnieszka Majkowska-Pilip*, Weronika Gawęda, Kinga Żelechowska-Matysiak, Kamil Wawrowicz, Aleksander Bilewicz
    Academic press:
    Nanomaterials (rok: 2020, tom: 10, strony: 1366-1391), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/nano10071366 - link to the publication

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy